Filtered By:
Condition: Hives
Countries: USA Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 16 results found since Jan 2013.
Diagnosed Allergic Conditions in Adults: United States, 2021
This report uses 2021 National Health Interview Survey (NHIS) data to describe the prevalence of seasonal allergies, eczema, and food allergies in adults in the United States.PMID:36700875
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Amanda E Ng Peter Boersma Source Type: research
Diagnosed Allergic Conditions in Children Aged 0-17 Years: United States, 2021
This report describes the percentage of children who had diagnosed seasonal allergy, eczema, or food allergy by sex, age, and race and Hispanic origin from the 2021 National Health Interview Survey (NHIS).PMID:36700870
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Benjamin Zablotsky Lindsey I Black Lara J Akinbami Source Type: research
Diagnosed Allergic Conditions in Adults: United States, 2021
This report uses 2021 National Health Interview Survey (NHIS) data to describe the prevalence of seasonal allergies, eczema, and food allergies in adults in the United States.PMID:36700875
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Amanda E Ng Peter Boersma Source Type: research
Diagnosed Allergic Conditions in Children Aged 0-17 Years: United States, 2021
This report describes the percentage of children who had diagnosed seasonal allergy, eczema, or food allergy by sex, age, and race and Hispanic origin from the 2021 National Health Interview Survey (NHIS).PMID:36700870
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Benjamin Zablotsky Lindsey I Black Lara J Akinbami Source Type: research
Diagnosed Allergic Conditions in Adults: United States, 2021
This report uses 2021 National Health Interview Survey (NHIS) data to describe the prevalence of seasonal allergies, eczema, and food allergies in adults in the United States.PMID:36700875
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Amanda E Ng Peter Boersma Source Type: research
Diagnosed Allergic Conditions in Children Aged 0-17 Years: United States, 2021
This report describes the percentage of children who had diagnosed seasonal allergy, eczema, or food allergy by sex, age, and race and Hispanic origin from the 2021 National Health Interview Survey (NHIS).PMID:36700870
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Benjamin Zablotsky Lindsey I Black Lara J Akinbami Source Type: research
Diagnosed Allergic Conditions in Adults: United States, 2021
This report uses 2021 National Health Interview Survey (NHIS) data to describe the prevalence of seasonal allergies, eczema, and food allergies in adults in the United States.PMID:36700875
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Amanda E Ng Peter Boersma Source Type: research
Diagnosed Allergic Conditions in Children Aged 0-17 Years: United States, 2021
This report describes the percentage of children who had diagnosed seasonal allergy, eczema, or food allergy by sex, age, and race and Hispanic origin from the 2021 National Health Interview Survey (NHIS).PMID:36700870
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Benjamin Zablotsky Lindsey I Black Lara J Akinbami Source Type: research
Diagnosed Allergic Conditions in Adults: United States, 2021
This report uses 2021 National Health Interview Survey (NHIS) data to describe the prevalence of seasonal allergies, eczema, and food allergies in adults in the United States.PMID:36700875
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Amanda E Ng Peter Boersma Source Type: research
Diagnosed Allergic Conditions in Children Aged 0-17 Years: United States, 2021
This report describes the percentage of children who had diagnosed seasonal allergy, eczema, or food allergy by sex, age, and race and Hispanic origin from the 2021 National Health Interview Survey (NHIS).PMID:36700870
Source: NCHS data brief - January 26, 2023 Category: American Health Authors: Benjamin Zablotsky Lindsey I Black Lara J Akinbami Source Type: research
Roche receives U.S. FDA Emergency Use Authorization for its high-throughput test to detect monkeypox virus
In May 2022, Roche was one of the first companies to develop a suite of tests to detect themonkeypox virus and aid in the understanding of why and how the disease is spreading.cobas MPXV for use oncobas 6800/8800 Systems is the firstmonkeypox virus test granted EUA following evaluation in actual patient samples rather than just samples formulated in the laboratory.High-throughput solutions enable rapid results, allowing individuals to avoid additional testing or unnecessary isolation, and supporting access to appropriate treatment as soon as possible.Basel, 16 November 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced to...
Source: Roche Media News - November 16, 2022 Category: Pharmaceuticals Source Type: news
FDA approves Xolair ® (omalizumab) for adults with nasal polyps
Basel, 01 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application (sBLA) for Xolair® (omalizumab) for the add-on maintenance treatment of nasal polyps in adult patients 18 years of age and older with inadequate response to nasal corticosteroids.1 Nasal polyps can lead to a loss of smell and nasal congestion, and frequently co-occur with other respiratory conditions, such as allergies and asthma. With this approval, Xolair is now the first biologic for the treatment ...
Source: Roche Media News - December 1, 2020 Category: Pharmaceuticals Source Type: news
Why Parents Are Turning to a Controversial Treatment for Food Allergies
This article was originally published on Undark. Read the original article.
Source: TIME: Health - August 15, 2019 Category: Consumer Health News Authors: Esther Landhuis / Undark Tags: Uncategorized allergies health onetime syndication Source Type: news
Prevalence and characteristics of hospital inpatients with reported fluoroquinolone allergy
Conclusion The prevalence of patients claiming a quinolone allergy in the study hospital was 2%. Common hypersensitivity reactions were reported. Data tended to support a possible association between intravenous contrast allergy and quinolone allergy.
Source: International Journal of Clinical Pharmacy - March 14, 2018 Category: Drugs & Pharmacology Source Type: research
